Inhibition of rotavirus infection in vitro and in vivo by a synthetic peptide from VP4.
Vaccine
; 16(9-10): 916-20, 1998.
Article
en En
| MEDLINE
| ID: mdl-9682337
ABSTRACT
A synthetic peptide corresponding to bovine rotavirus C486 (BRV) VP4 amino acid sequence 232-255 (VP4-peptide) was studied with the objective of defining the origin of the protective immune response reported previously by Ijaz et al. (J. Virol. 1991, 65, 3106-3113). Pretreatment of MA-104 cells with the VP4-peptide before infection with rotavirus prevented both the attachment of 35S-labelled virus and plaque formation in vitro. In vivo studies using a murine rotavirus model demonstrated that intragastric administration of VP4-peptide protected subjects from challenge with virulent rotavirus. These results clearly indicate the importance of this epitope in virus-cell interactions and their potential as a rotavirus vaccine candidate.
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Fragmentos de Péptidos
/
Infecciones por Rotavirus
/
Cápside
/
Rotavirus
/
Proteínas de la Cápside
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Vaccine
Año:
1998
Tipo del documento:
Article